Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study locations section now shows a separate 'Locations' heading with 'Ontario' listed, replacing the previous 'Ontario Locations' label. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision note updated from v3.2.0 to v3.3.2; no study data or content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding/operating-status notice, including statements about potential delays due to funding and links to operating status resources. The page no longer displays this general status information.SummaryDifference0.4%

- Check54 days agoChange DetectedResults for NCT03316872 have been posted, with associated dates shown in the study record. The study record history has been updated to reflect these results.SummaryDifference0.5%

- Check83 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.